Ciprofloxacine Baxter 2 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ciprofloxacine baxter 2 mg/ml inf. sol. i.v. vial

baxter deutschland gmbh - ciprofloxacin lactate 2,544 mg/ml - eq. ciprofloxacin 2 mg/ml - solution for infusion - 2 mg/ml - ciprofloxacin lactate - ciprofloxacin

Ciprofloxacine Baxter 2 mg/ml inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ciprofloxacine baxter 2 mg/ml inf. sol. i.v.

baxter deutschland gmbh - ciprofloxacin lactate 2,544 mg/ml - eq. ciprofloxacin 2 mg/ml - solution for infusion - 2 mg/ml - ciprofloxacin lactate 2.54 mg/ml - ciprofloxacin

Ciprofloxacine Baxter 2 mg/ml inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ciprofloxacine baxter 2 mg/ml inf. sol. i.v.

baxter deutschland gmbh - ciprofloxacin lactate 2,544 mg/ml - eq. ciprofloxacin 2 mg/ml - solution for infusion - 2 mg/ml - ciprofloxacin lactate 2.54 mg/ml - ciprofloxacin

Ciprofloxacine Baxter 2 mg/ml inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ciprofloxacine baxter 2 mg/ml inf. sol. i.v.

baxter deutschland gmbh - ciprofloxacin lactate 2,544 mg/ml - eq. ciprofloxacin 2 mg/ml - solution for infusion - 2 mg/ml - ciprofloxacin lactate 2.54 mg/ml - ciprofloxacin

Ketamine-Baxter New Zealand - English - Medsafe (Medicines Safety Authority)

ketamine-baxter

baxter healthcare ltd - ketamine hydrochloride 115.34 mg/ml equivalent to ketamine 100 mg/ml - solution for injection - 100 mg/ml - active: ketamine hydrochloride 115.34 mg/ml equivalent to ketamine 100 mg/ml excipient: nitrogen water for injection - ketamine-baxter is recommended: 1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine-baxter is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

BUPIVACAINE-BAXTER bupivacaine hydrochloride (as monohydrate) 50 mg/10 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

bupivacaine-baxter bupivacaine hydrochloride (as monohydrate) 50 mg/10 ml solution for injection vial

baxter healthcare pty ltd - bupivacaine hydrochloride, quantity: 5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 5.28 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - indications ,bupivacaine-baxter is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: ,surgical anaesthesia ,epidural block for surgery ,field block (minor and major nerve blocks and infiltration). ,analgesia ,continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. ,field block (minor nerve block and infiltration).

BUPIVACAINE-BAXTER bupivacaine hydrochloride (as monohydrate) 50 mg/20 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

bupivacaine-baxter bupivacaine hydrochloride (as monohydrate) 50 mg/20 ml solution for injection vial

baxter healthcare pty ltd - bupivacaine hydrochloride, quantity: 2.5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 2.64 mg/ml) - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium chloride; sodium hydroxide - indications ,bupivacaine-baxter is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: ,surgical anaesthesia ,epidural block for surgery ,field block (minor and major nerve blocks and infiltration). ,analgesia ,continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. ,field block (minor nerve block and infiltration).

FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 20 MG2 ML Singapore - English - HSA (Health Sciences Authority)

furosemide-baxter solution for injection 20 mg2 ml

baxter healthcare (asia) pte ltd - furosemide - injection, solution - furosemide 20 mg/2 ml

Furosemide-Baxter New Zealand - English - Medsafe (Medicines Safety Authority)

furosemide-baxter

baxter healthcare ltd - furosemide 10mg - solution for injection - 10 mg/ml - active: furosemide 10mg excipient: hydrochloric acid sodium hydroxide ph adjustment sodium chloride sodium hydroxide water for injection - furosemide-baxter injection is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. furosemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations.

BAXTER IRINOTECAN Australia - English - Department of Health (Therapeutic Goods Administration)

baxter irinotecan

baxter healthcare pty ltd - irinotecan hydrochloride -